198 related articles for article (PubMed ID: 11342539)
1. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
[TBL] [Abstract][Full Text] [Related]
2. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.
Parmer RJ; Mahata M; Gong Y; Mahata SK; Jiang Q; O'Connor DT; Xi XP; Miles LA
J Clin Invest; 2000 Oct; 106(7):907-15. PubMed ID: 11018079
[TBL] [Abstract][Full Text] [Related]
3. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion.
Jiang Q; Yasothornsrikul S; Taupenot L; Miles LA; Parmer RJ
Ann N Y Acad Sci; 2002 Oct; 971():445-9. PubMed ID: 12438162
[TBL] [Abstract][Full Text] [Related]
4. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Biswas N; Vaingankar SM; Mahata M; Das M; Gayen JR; Taupenot L; Torpey JW; O'Connor DT; Mahata SK
Endocrinology; 2008 Feb; 149(2):749-57. PubMed ID: 17991725
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides.
Biswas N; Rodriguez-Flores JL; Courel M; Gayen JR; Vaingankar SM; Mahata M; Torpey JW; Taupenot L; O'Connor DT; Mahata SK
Endocrinology; 2009 Aug; 150(8):3547-57. PubMed ID: 19372204
[TBL] [Abstract][Full Text] [Related]
7. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
8. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
[TBL] [Abstract][Full Text] [Related]
9. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
Taylor CV; Taupenot L; Mahata SK; Mahata M; Wu H; Yasothornsrikul S; Toneff T; Caporale C; Jiang Q; Parmer RJ; Hook VY; O'Connor DT
J Biol Chem; 2000 Jul; 275(30):22905-15. PubMed ID: 10781584
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells.
Miles LA; Andronicos NM; Baik N; Parmer RJ
J Neurosci; 2006 Dec; 26(50):13017-24. PubMed ID: 17167091
[TBL] [Abstract][Full Text] [Related]
11. Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells.
Sahu BS; Mahata S; Bandyopadhyay K; Mahata M; Avolio E; Pasqua T; Sahu C; Bandyopadhyay GK; Bartolomucci A; Webster NJG; Van Den Bogaart G; Fischer-Colbrie R; Corti A; Eiden LE; Mahata SK
Cell Tissue Res; 2019 Apr; 376(1):51-70. PubMed ID: 30467710
[TBL] [Abstract][Full Text] [Related]
12. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
13. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.
Colombo B; Longhi R; Marinzi C; Magni F; Cattaneo A; Yoo SH; Curnis F; Corti A
J Biol Chem; 2002 Nov; 277(48):45911-9. PubMed ID: 12297497
[TBL] [Abstract][Full Text] [Related]
15. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
Takiyyuddin MA; Cervenka JH; Sullivan PA; Pandian MR; Parmer RJ; Barbosa JA; O'Connor DT
Circulation; 1990 Jan; 81(1):185-95. PubMed ID: 2404624
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.
Mahata SK; Mahata M; Parmer RJ; O'Connor DT
J Biol Chem; 1999 Jan; 274(5):2920-8. PubMed ID: 9915830
[TBL] [Abstract][Full Text] [Related]
17. Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion.
Galindo E; Rill A; Bader MF; Aunis D
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1426-30. PubMed ID: 1996343
[TBL] [Abstract][Full Text] [Related]
18. Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway.
Parmer RJ; Xi XP; Wu HJ; Helman LJ; Petz LN
J Clin Invest; 1993 Aug; 92(2):1042-54. PubMed ID: 8394383
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS.
Lee JC; Hook V
Biochemistry; 2009 Jun; 48(23):5254-62. PubMed ID: 19405523
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.
Gadroy P; Stridsberg M; Capon C; Michalski JC; Strub JM; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
J Biol Chem; 1998 Dec; 273(51):34087-97. PubMed ID: 9852066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
